DiviDrip · STOK

STOK — Stoke Therapeutics, Inc.

STOK is Stoke Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $29.81. Market cap: $1.92B. Capital Quality Rank: 89/100 — Elite compounder.

Stock snapshot

Price$29.81
Market cap$1.92B
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)89 / 100 · Elite compounder
ROIC (TTM)-6.1%
Revenue CAGR (3y)145.9%
Shareholder buyback yield-8.80%
Altman Z-score zoneSafe

About STOK

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Listed2019Employees170HQBedford, MASectorHealthcareWebsitestoketherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside STOK. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is STOK's current stock price?

STOK (Stoke Therapeutics, Inc.) is currently trading at $29.81.

Does STOK pay a dividend?

STOK (Stoke Therapeutics, Inc.) does not currently pay a regular dividend.

What is STOK's Capital Quality Rank?

STOK has a Capital Quality Rank of 89/100 — Elite compounder. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track STOK in DiviDrip

Add STOK to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow